Large-cell lymphoma: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Large-cell lymphoma | |||
| image = [[File:Primary_mediastinal_large_B-cell_lymphoma_-_high_mag.jpg|250px]] | |||
| caption = Micrograph of primary mediastinal large B-cell lymphoma | |||
| field = [[Hematology]] | |||
| symptoms = [[Lymphadenopathy]], [[fever]], [[night sweats]], [[weight loss]] | |||
| complications = [[Tumor lysis syndrome]], [[infection]] | |||
| onset = Variable | |||
| duration = Chronic | |||
| types = [[Diffuse large B-cell lymphoma]], [[Anaplastic large-cell lymphoma]], [[Primary mediastinal large B-cell lymphoma]] | |||
| causes = Unknown, potential [[genetic mutations]] | |||
| risks = [[Immunosuppression]], [[Epstein-Barr virus]] infection | |||
| diagnosis = [[Biopsy]], [[immunohistochemistry]], [[flow cytometry]] | |||
| differential = [[Hodgkin lymphoma]], [[Burkitt lymphoma]], [[Follicular lymphoma]] | |||
| prevention = None | |||
| treatment = [[Chemotherapy]], [[radiation therapy]], [[stem cell transplant]] | |||
| prognosis = Variable, depends on subtype and stage | |||
| frequency = Common among [[non-Hodgkin lymphomas]] | |||
}} | |||
'''Large-cell lymphoma''' is a type of [[non-Hodgkin lymphoma]] (NHL) characterized by large malignant [[lymphocyte]]s with prominent nuclei. It encompasses several subtypes, including [[Diffuse large B-cell lymphoma]] (DLBCL), the most common form of NHL in adults, and [[Primary mediastinal B-cell lymphoma]] (PMBCL), a subtype that typically arises in the [[thymus]]. Large-cell lymphomas are aggressive malignancies that require prompt diagnosis and treatment. | '''Large-cell lymphoma''' is a type of [[non-Hodgkin lymphoma]] (NHL) characterized by large malignant [[lymphocyte]]s with prominent nuclei. It encompasses several subtypes, including [[Diffuse large B-cell lymphoma]] (DLBCL), the most common form of NHL in adults, and [[Primary mediastinal B-cell lymphoma]] (PMBCL), a subtype that typically arises in the [[thymus]]. Large-cell lymphomas are aggressive malignancies that require prompt diagnosis and treatment. | ||
==Etiology and Risk Factors== | ==Etiology and Risk Factors== | ||
The exact cause of large-cell lymphoma is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Risk factors may include: | The exact cause of large-cell lymphoma is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Risk factors may include: | ||
| Line 7: | Line 26: | ||
* Exposure to certain chemicals or radiation | * Exposure to certain chemicals or radiation | ||
* A history of certain infections, such as [[Epstein-Barr virus]] (EBV) associated with DLBCL | * A history of certain infections, such as [[Epstein-Barr virus]] (EBV) associated with DLBCL | ||
==Pathophysiology== | ==Pathophysiology== | ||
Large-cell lymphomas originate from the transformation of either [[B-cell lymphocytes]] or [[T-cell lymphocytes]], leading to the uncontrolled proliferation of large, abnormal lymphocytes. These malignant cells can accumulate in lymphoid tissues, such as [[lymph nodes]], the [[spleen]], and the [[bone marrow]], and may spread to other organs, causing a wide range of symptoms. | Large-cell lymphomas originate from the transformation of either [[B-cell lymphocytes]] or [[T-cell lymphocytes]], leading to the uncontrolled proliferation of large, abnormal lymphocytes. These malignant cells can accumulate in lymphoid tissues, such as [[lymph nodes]], the [[spleen]], and the [[bone marrow]], and may spread to other organs, causing a wide range of symptoms. | ||
==Clinical Features== | ==Clinical Features== | ||
Symptoms of large-cell lymphoma can vary depending on the subtype and the organs involved but may include: | Symptoms of large-cell lymphoma can vary depending on the subtype and the organs involved but may include: | ||
| Line 18: | Line 35: | ||
* Fatigue | * Fatigue | ||
* Difficulty breathing or chest pain (in cases where the mediastinum is involved) | * Difficulty breathing or chest pain (in cases where the mediastinum is involved) | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of large-cell lymphoma typically involves a combination of: | Diagnosis of large-cell lymphoma typically involves a combination of: | ||
| Line 25: | Line 41: | ||
* Imaging studies, such as [[Computed tomography|CT scans]] or [[Positron emission tomography|PET scans]] | * Imaging studies, such as [[Computed tomography|CT scans]] or [[Positron emission tomography|PET scans]] | ||
* Biopsy of affected tissue, which is essential for confirming the diagnosis and determining the specific subtype of lymphoma | * Biopsy of affected tissue, which is essential for confirming the diagnosis and determining the specific subtype of lymphoma | ||
==Treatment== | ==Treatment== | ||
Treatment for large-cell lymphoma varies depending on the subtype, stage, and patient's overall health but may include: | Treatment for large-cell lymphoma varies depending on the subtype, stage, and patient's overall health but may include: | ||
| Line 32: | Line 47: | ||
* Stem cell transplantation in cases of relapse or refractory disease | * Stem cell transplantation in cases of relapse or refractory disease | ||
* Targeted therapy and immunotherapy for certain subtypes and situations | * Targeted therapy and immunotherapy for certain subtypes and situations | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for large-cell lymphoma depends on a variety of factors, including the subtype, stage at diagnosis, patient's age, and response to treatment. The International Prognostic Index (IPI) is commonly used to help predict outcomes. Despite being aggressive, many cases of large-cell lymphoma, especially DLBCL, can be cured with appropriate treatment. | The prognosis for large-cell lymphoma depends on a variety of factors, including the subtype, stage at diagnosis, patient's age, and response to treatment. The International Prognostic Index (IPI) is commonly used to help predict outcomes. Despite being aggressive, many cases of large-cell lymphoma, especially DLBCL, can be cured with appropriate treatment. | ||
==Prevention== | ==Prevention== | ||
There are no specific measures to prevent large-cell lymphoma. However, maintaining a healthy immune system and avoiding known risk factors may reduce the risk. | There are no specific measures to prevent large-cell lymphoma. However, maintaining a healthy immune system and avoiding known risk factors may reduce the risk. | ||
[[Category:Hematologic diseases]] | [[Category:Hematologic diseases]] | ||
[[Category:Lymphoma]] | [[Category:Lymphoma]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
Latest revision as of 21:14, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Large-cell lymphoma | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Lymphadenopathy, fever, night sweats, weight loss |
| Complications | Tumor lysis syndrome, infection |
| Onset | Variable |
| Duration | Chronic |
| Types | Diffuse large B-cell lymphoma, Anaplastic large-cell lymphoma, Primary mediastinal large B-cell lymphoma |
| Causes | Unknown, potential genetic mutations |
| Risks | Immunosuppression, Epstein-Barr virus infection |
| Diagnosis | Biopsy, immunohistochemistry, flow cytometry |
| Differential diagnosis | Hodgkin lymphoma, Burkitt lymphoma, Follicular lymphoma |
| Prevention | None |
| Treatment | Chemotherapy, radiation therapy, stem cell transplant |
| Medication | N/A |
| Prognosis | Variable, depends on subtype and stage |
| Frequency | Common among non-Hodgkin lymphomas |
| Deaths | N/A |
Large-cell lymphoma is a type of non-Hodgkin lymphoma (NHL) characterized by large malignant lymphocytes with prominent nuclei. It encompasses several subtypes, including Diffuse large B-cell lymphoma (DLBCL), the most common form of NHL in adults, and Primary mediastinal B-cell lymphoma (PMBCL), a subtype that typically arises in the thymus. Large-cell lymphomas are aggressive malignancies that require prompt diagnosis and treatment.
Etiology and Risk Factors[edit]
The exact cause of large-cell lymphoma is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Risk factors may include:
- Age, with a higher incidence in older adults
- Immune system deficiencies or disorders
- Exposure to certain chemicals or radiation
- A history of certain infections, such as Epstein-Barr virus (EBV) associated with DLBCL
Pathophysiology[edit]
Large-cell lymphomas originate from the transformation of either B-cell lymphocytes or T-cell lymphocytes, leading to the uncontrolled proliferation of large, abnormal lymphocytes. These malignant cells can accumulate in lymphoid tissues, such as lymph nodes, the spleen, and the bone marrow, and may spread to other organs, causing a wide range of symptoms.
Clinical Features[edit]
Symptoms of large-cell lymphoma can vary depending on the subtype and the organs involved but may include:
- Painless swelling of lymph nodes in the neck, armpits, or groin
- Unexplained weight loss
- Fever and night sweats
- Fatigue
- Difficulty breathing or chest pain (in cases where the mediastinum is involved)
Diagnosis[edit]
Diagnosis of large-cell lymphoma typically involves a combination of:
- Physical examination
- Laboratory tests, including complete blood count (CBC) and lactate dehydrogenase (LDH) levels
- Imaging studies, such as CT scans or PET scans
- Biopsy of affected tissue, which is essential for confirming the diagnosis and determining the specific subtype of lymphoma
Treatment[edit]
Treatment for large-cell lymphoma varies depending on the subtype, stage, and patient's overall health but may include:
- Chemotherapy, often combined with the monoclonal antibody rituximab for B-cell lymphomas
- Radiation therapy, particularly for localized disease
- Stem cell transplantation in cases of relapse or refractory disease
- Targeted therapy and immunotherapy for certain subtypes and situations
Prognosis[edit]
The prognosis for large-cell lymphoma depends on a variety of factors, including the subtype, stage at diagnosis, patient's age, and response to treatment. The International Prognostic Index (IPI) is commonly used to help predict outcomes. Despite being aggressive, many cases of large-cell lymphoma, especially DLBCL, can be cured with appropriate treatment.
Prevention[edit]
There are no specific measures to prevent large-cell lymphoma. However, maintaining a healthy immune system and avoiding known risk factors may reduce the risk.
